Methods
hemorrhage
HEMORRHAGE, MAY
This study was a two-group non-blinded randomized clinical trial conducted on 98 women referred to the maternity ward of Al-Zahra Hospital, Rasht, in 2021. The protocol of the trial was approved by the Ethics Committee of Guilan University of Medical Sciences (code: IR.GUMS.REC.1400.309) and registered at the Iranian Clinical Trial Registration Center (code: IRCT20210607051505N2). Then, a letter of introduction was presented to the head of Al-Zahra Hospital, Rasht, and sampling was done. In addition to obtaining informed consent, the participants were informed about the study's objectives, its method, and the confidentiality of the information. Free pads in the same size and brand were provided to all participants. They were also assured that at the end of 24 h, they would be informed of the normal or abnormal amount of hemorrhage. The corresponding nurse and ward manager will be informed if the excessive hemorrhage is detected. The study lasted from November 2021 to May 2022.